Invention Grant
- Patent Title: Protocol for monitoring direct thrombin inhibition
- Patent Title (中): 监测直接凝血酶抑制的方案
-
Application No.: US11753071Application Date: 2007-05-24
-
Publication No.: US08008086B2Publication Date: 2011-08-30
- Inventor: Eli Cohen , Roslyn Cohen
- Applicant: Eli Cohen , Roslyn Cohen
- Applicant Address: US IL Niles
- Assignee: Cora Healthcare, Inc.
- Current Assignee: Cora Healthcare, Inc.
- Current Assignee Address: US IL Niles
- Main IPC: G01N33/86
- IPC: G01N33/86 ; G01N33/48
Abstract:
A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit evaluation of hemostasis therapies including anticoagulation therapies such as direct thrombin inhibition therapies.
Public/Granted literature
- US20080038828A1 Protocol for Monitoring Direct Thrombin Inhibition Public/Granted day:2008-02-14
Information query
IPC分类:
